TGFB1 and glioma: When we divided patients into ‘‘low’’ and ‘‘high’’ groups based on the median value of TGF-β, high TGF-β expression was associated with poor patient survival in the glioma samples and TCGA database (Supplementary Figs. 6a, 7a).